Evaluation of Therapeutic Strategies to Reduce the Number of Thrombotic Events in Patients With Polycythemia Vera and Essential Thrombocythemia

Thrombosis is the largest contributor to morbidity and mortality in patients with polycythemia vera (PV) and essential thrombocythemia (ET). Our understanding of the risk factors and pathophysiology of thrombosis in PV and ET patients is developing, including recent insights into the role of aberran...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Douglas Tremblay, Heidi E. Kosiorek, Amylou C. Dueck, Ronald Hoffman
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Frontiers Media S.A. 2021-02-01
coleção:	Frontiers in Oncology
Assuntos:	thrombosis essential thrombocythemia polycythemia vera myeloproliferative surrogate endpoint study design
Acesso em linha:	https://www.frontiersin.org/articles/10.3389/fonc.2020.636675/full
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!